Lilly(Eli) & Co

LLY

$544.45

+87.6% last 12 months

PRIMECAP Management Holding value: $12.8 Billion Ken Fisher Holding value: $2.31 Billion Jeremy Grantham Holding value: $444 Million Tiger Global Holding value: $394 Million Ken Griffin Holding value: $297 Million Stanley Druckenmiller Holding value: $292 Million Ray Dalio Holding value: $62 Million Steven Cohen Holding value: $50 Million Ron Baron Holding value: $18.8 Million Mario Gabelli Holding value: $17.1 Million Jefferies Group Holding value: $14.5 Million Jim Simons Holding value: $7.08 Million Joel Greenblatt Holding value: $1.9 Million John Paulson Holding value: $0 Richard Pzena Holding value: $0 Andreas Halvorsen Holding value: $0 Julian Robertson Holding value: $0 Tom Russo Holding value: $0 Chris Davis Holding value: $0 George Soros Holding value: $0 Bill Gates Holding value: $0 David Tepper Holding value: $0

Market Cap

$522 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$299.74 - $601.84

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

80.37x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$4.35 (0.79%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $522 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $538 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $4.35 (0.79%)
1 Year Return Profit or loss of share price change plus dividend yield. +88.4%
52-Week High Highest share price in the last 52 weeks. $601.84
52-Week Low Lowest share price in the last 52 weeks. $299.74
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.36
Outstanding Shares The number of shares the company has issued and are held by stockholders. 949 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 2.84 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 80.37
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 94.43
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $7.19
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 17.56
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 49.5
Enterprise Value to Revenue Enterprise value divided by revenue 18.24
Enterprise Value to EBIT Enterprise Value divided by EBIT 68.29
Total Debt to Enterprise Value Total debt divided by enterprise value 0.03
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.7

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $29.5 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $23 Billion
EBIT Earnings before tax and interest payments. $7.88 Billion
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $6.5 Billion
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 22.01%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +85.1%
Return on Equity Equity divided by market cap. 58.73%
Return on Assets Indicates a company's profitability in relation to its total assets. 11.85%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 21.96%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q4 2022 Q1 2023 Q2 2023 Q3 2023

About Lilly(Eli) & Co

CEO: David Ricks

Industry: Pharmaceutical Preparation Manufacturing

Similar stocks

Merck & Co Inc
Merck & Co Inc
Johnson & Johnson
Johnson & Johnson
Pfizer Inc.
Pfizer Inc.
Sanofi - ADR
Sanofi - ADR
GSK Plc - ADR
GSK Plc - ADR
Abbvie Inc
Abbvie Inc
AMGEN Inc.
AMGEN Inc.
Novartis AG - ADR
Novartis AG - ADR
Astrazeneca plc - ADR
Astrazeneca plc - ADR

News

Eli Lilly settles whistleblower lawsuit over manufacturing problems

Eli Lilly settles whistleblower lawsuit over manufacturing problems

https://www.investing.com/news/stock-market-news/eli-lilly-settles-whistleblower-lawsuit-over-manufacturing-problems-3185775

Investing.com Investing.com, 1 day ago
New Mexico Educational Retirement Board Buys 1,800 Shares of Eli Lilly and Company (NYSE:LLY)

New Mexico Educational Retirement Board Buys 1,800 Shares of Eli Lilly and Company (NYSE:LLY)

… Latest Stock Analysis on Eli Lilly and Company Eli Lilly and Company Stock … year. About Eli Lilly and Company (Free Report) Eli Lilly and Company discover...

EIN News Pharmaceuticals EIN News Pharmaceuticals, 5 days ago
500 Shares in Eli Lilly and Company (NYSE:LLY) Purchased by Martin Capital Partners LLC

500 Shares in Eli Lilly and Company (NYSE:LLY) Purchased by Martin Capital Partners LLC

… for the current fiscal year. Eli Lilly and Company Announces Dividend The … on LLY About Eli Lilly and Company (Free Report) Eli Lilly and Company discover...

EIN News Pharmaceuticals EIN News Pharmaceuticals, 5 days ago
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

Biotech has long seemed to move slower than its fellow tech fields due to the complexity of biological systems and the difficulty of drug regulations. Howeve...

InvestorPlace InvestorPlace, 7 days ago
Never miss a trade
To improve your user experience we use cookies.